24 /100
LOW RISK
Score updated Jul 13, 2026

MLAB — Mesa Laboratories, Inc. Dilution Risk Tracker

Track MLAB dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track MLAB — Get alerts when the score changes →

As of July 13, 2026, Mesa Laboratories, Inc. (MLAB) has a DilutionWatch DilutionScore of 24/100, rated LOW dilution risk. Mesa Laboratories, Inc. has a market capitalization of $563.64M, 5.52M shares outstanding, 161 institutional holders tracked. Key dilution vectors include approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
0
📊 Float Risk
15
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for MLAB.
🔔 Track MLAB — Get forecast alerts →

💹 Market Data

Market Cap$563.64M
Shares Outstanding5.52M
Float4.96M
Cash$26.93M
Debt$19.76M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 18.6% shares (2026Q1 vs prior)
161 institutional holders · 5.70M shares
#1 MORGAN STANLEY 592.7K shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 465.3K shares
#3 Long Path Partners LP 405.6K shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest276.2K
Days to Cover1.3
% of Float5.6%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Mar 31, 2022
4 INSIDER TRANSACTION Mar 10, 2026
4 INSIDER TRANSACTION Mar 10, 2026
4 INSIDER TRANSACTION Mar 10, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for MLAB Shareholders

Mesa Laboratories, Inc. (MLAB) has a DilutionScore of 24/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for MLAB shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for MLAB in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for MLAB alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track MLAB Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking MLAB — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for MLAB
📊 MLAB FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 MLAB Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.